Indian startup Ceremorphic has launched a life sciences division to accelerate drug development using its AI chip technology platform. The Ceremorphic life sciences division employs a new technology platform called BioCompDiscoverX. The company's goal is to identify better candidate molecules from the outset and bring new drugs to market faster and at a lower cost.